Physician profile
Michael M Givertz
NPI 1265499560
$146,865.92
in general payments reported to CMS, 2019-2025
22 companies · $19K in 2025
The $19K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $16K · 2021: $16K · 2022: $25K · 2023: $17K · 2024: $5,940 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $9,924 · Food and Beverage: $3,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,430.00 |
| Travel and Lodging | $9,923.89 |
| Food and Beverage | $3,509.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $69,697.27 | 2019-2025 | Verquvo |
| Edwards Lifesciences Corporation | $39,000.00 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $15,863.78 | 2019 | |
| Acorda Therapeutics, INC | $10,005.15 | 2019 | |
| Baxter Healthcare | $4,203.00 | 2019 | |
| Abbott Laboratories | $3,905.06 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $1,871.55 | 2025 | |
| Abiomed | $469.39 | 2019-2023 | Impella |
| Transmedics, INC. | $439.00 | 2023 | Organ Care System |
| Cvrx, INC. | $316.66 | 2023-2025 | Barostim Neo System |
| Endotronix, INC. | $294.18 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Medtronic, INC. | $143.46 | 2024 | Micra |
| Biotronik INC. | $140.42 | 2019 | |
| Medtronic Vascular, INC. | $126.09 | 2019 | |
| United Therapeutics Corporation | $103.42 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $85.50 | 2023 | |
| Amgen INC. | $77.77 | 2019-2023 | Repatha |
| Shockwave Medical, INC | $64.46 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $59.76 | 2025 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Givertz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.